Oscar Health, Inc.

OSCR Healthcare Healthcare Plans

Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024. In the quarter to June 2026, revenue grew 70.4%, EPS grew 234.8%, free cash flow grew 316.3% and total debt rose 43.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

33.79 0.22 −0.65%
Market cap
$10.4B
P/E
19.8×
Fwd P/E
29.7×
Dividend yield
—
F-score
3/9
Altman Z
1.07
Beneish M
−2.18
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 3 4 6
ROE
(22.27%) (44.38%) (2.63%) 34.24%
ROA
(4.77%) (7.94%) (0.52%) 6.25%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
21.61% 35.87% 3.53% (15.35%)
Average Days of Receivables
17.40 18.67 26.11 18.05
Free Cash Flow per Share
2.84 4.03 9.39 14.49
Free Cash Flow
735.64 1,058.48 2,799.15 4,379.95
Capital Expenditures
(34.13) (36.37) (36.14) (38.62)
Other line items
Cash ROIC
19.05% 25.29% 40.55% 66.74%
Accounts Receivable Turnover
25.02 23.90 17.42 23.38
Accounts Payable Turnover
2.79 2.48 1.99 1.84
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
150.40 171.09 231.45 254.32
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.02 0.01 0.47 (0.07)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
17.76% 17.52% 17.09% 15.86%
Share Based Compensation of Revenue
0.85% 0.75% 0.59% 0.49%
Interest Coverage
(8.51) (22.52) 0.62 39.73
Operating CF/Net income
(3.15) (2.47) (71.91) 8.02
Depreciation/Fixed assets
0.00 0.01 0.03 0.02
Capex/Depreciation
(150.35) (49.89) (14.85) (17.29)
Revenue per Share
43.54 44.60 44.61 50.69
Operating CF per Share
2.97 4.17 9.51 14.62
Capex per Share
(0.13) (0.14) (0.12) (0.13)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates